Karimipour Saga I: Setting Boundaries
“The business of selling authorships and citations needs a steady supply of paper-shaped vehicles. It is most efficient to produce these in assembly lines that focus on a narrow topic.” – Maarten van Kampen
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
“The business of selling authorships and citations needs a steady supply of paper-shaped vehicles. It is most efficient to produce these in assembly lines that focus on a narrow topic.” – Maarten van Kampen
Schneider Shorts 29.03.2024 – German medical elites special: with Gender, Diversity and a retirement party in Ulm, an incomplete investigation in Göttingen, naughty mentees of a Heidelberg pharmacologist, plus investigation outcomes in USA, King’s first retraction, and why you must have a coffee right now.
Schneider Shorts of 15.03.2024 – Alzheimer cures from China, Spain and the FDA, a nasty ork sanctioned in Germany, with a Lord of the Biochar Rings, medals for the bestest science ever, a brain breakthrough, and finally, what can University of Ulm do against Schneider?
Schneider Shorts of 23.02.2024 – MDPI’s war on Ukraine, naughty Italian editor at Elsevier, Frontiers shocked by cartoon penis, with an attention-seeking Nobelist, a half-investigation in Bochum, Finnish thief and abuser in Denmark, and a fake lizard finally exposed.
“the rarest, most sought-after token of recognition is when the Chen brothers steal your identity to use as a fictive co-author on one of their plagiarism gallimaufreys. For instance, “Bunnitru Daleanu” was based on (and memorialises) the nonpareil Rumanian mathematician Dumitru Baleanu – now resident in Turkey” – Smut Clyde
Meet Mohammad Taheri, PhD, a humble PhD student in Jena, Germany, and his equally unremarkable Iranian associate Dr Soudeh Ghafouri-Fard.
“Go and change the globe to a more positive future instead”
Schneider Shorts 2.02.2024 – Three stories about Dana Farber (including a Nobelist!), two stories about the Lille papermille (including a game!), with an “honest” plant scientist, doctors being rewarded, amazing corrections and informative retractions, and how another Nobelist’s cell therapy business ended up unsold.
“There is so much money flowing through this system that I don’t see what will stop the network of papermills and corrupt editors.” – Nick Wise
“I am not angry with the post-publication surgery that the publisher performed on the affected papers after discovering the shenanigans, scrubbing off the names of spurious reviewers. Just very disappointed.” – Smut Clyde






